These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 769960)

  • 1. 5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.
    Hum GJ; Bateman JR
    Cancer Chemother Rep; 1975; 59(6):1171-9. PubMed ID: 769960
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of concomitant drug treatment on toxic and therapeutic activity of 5-fluorouracil (5-FU; NSC-19893).
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Apr; 56(2):245-7. PubMed ID: 4557738
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
    Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
    Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 7. [5-Fluorouracil(5-FU) in the treatment of adenocarcinomas of the digestive tract (apropos of 13 cases)].
    Vinhafs JC; Ferreira AJ
    Hospital (Rio J); 1967 Feb; 71(2):453-74. PubMed ID: 5302398
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.
    Moertel CG; Childs DS; Reitemeier RJ; Colby MY; Holbrook MA
    Lancet; 1969 Oct; 2(7626):865-7. PubMed ID: 4186452
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
    Stolinsky DC; Pugh RP; Bateman JR
    Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893).
    Fortuny IE; Theologides A; Kennedy BJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):401-4. PubMed ID: 1097098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
    Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
    Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.
    Caballero GA; Ausman RK; Quebbeman EJ
    Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study.
    Machover D; Schwarzenberg L; Goldschmidt E; Tourani JM; Michalski B; Hayat M; Dorval T; Misset JL; Jasmin C; Maral R; Mathé G
    Cancer Treat Rep; 1982 Oct; 66(10):1803-7. PubMed ID: 6982099
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinoma.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):951-2. PubMed ID: 4614903
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion.
    Hillcoat BL; McCulloch PB; Figueredo AT; Ehsan MH; Rosenfeld JM
    Br J Cancer; 1978 Dec; 38(6):719-24. PubMed ID: 743489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.
    Ross PJ; Webb A; Cunningham D; Prendiville J; Norman AR; Oates J
    J Infus Chemother; 1996; 6(3):141-4. PubMed ID: 9229326
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxytetracycline, vehicle for therapeutic drugs, fluorouracil and nitrogen mustard, in the treatment of gastrointestinal tumors].
    Gordon B
    Hospital (Rio J); 1970 Apr; 77(4):1243-68. PubMed ID: 4939509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.